Results 151 to 160 of about 80,621 (311)

Regulation of Aldosterone Secretion by Substance P and the Neurokinin Type 1 Receptor in Aldosterone-Producing Adenomas. [PDF]

J Am Heart Assoc
Lopez AG, Duparc C, Renouf S, D'Agostino M, De Sousa K, Amar L, Defortescu G, Manceau G, Sabourin JC, Fernandes-Rosa FL, Zennaro MC, Meatchi T, Nicolas G, Louiset E, Lefebvre H.   +14 more
europepmc   +1 more source

Diabetic kidney disease, biomarkers, and finerenone

Diabetes, Obesity and Metabolism, Volume 28, Issue 4, Page 2582-2593, April 2026.
Abstract Diabetic kidney disease (DKD), the leading cause of kidney failure worldwide, is associated with an increased risk of cardiovascular disease (CVD). A complex pathobiology involving hemodynamic, metabolic, and immune dysregulation promotes inflammatory and fibrotic pathways that contribute to kidney disease progression and CVD in individuals ...
Ashish Verma, Ashish Upadhyay
wiley   +1 more source

The Clinical Impact of Corticosteroid Supplementation in Febrile Patients with Adrenal Insufficiency. [PDF]

Yonsei Med J
Kwon H, Lee SE, Park JH, Ko JW, Kim B.
europepmc   +1 more source

Washington University Medical Alumni Quarterly, July 1951 [PDF]

, 1951

core   +1 more source

Update on diagnosis, nonpharmacological treatment and prevention of Equine Gastric Ulcer Syndrome (EGUS)

Equine Veterinary Education, Volume 38, Issue 4, Page 206-219, April 2026.
Summary The term Equine Gastric Ulcer Syndrome (EGUS) has been used since 1999. As there are important differences, the terms Equine Squamous Gastric Disease (ESGD) and Equine Glandular Gastric Disease (EGGD) were introduced in 2015. Risk factors like dietary management, training regimens and drug side effects, as described for NSAIDs, predispose ...
R. Lensing, A. K. Barton
wiley   +1 more source

EndoCompass Project: Research Roadmap for Adrenal and Cardiovascular Endocrinology. [PDF]

Horm Res Paediatr
Husebye ES, Assié G, Krone N, Achermann JC, Altieri B, Amar L, Araujo-Castro M, Brown MJ, Casey RT, Claahsen-van der Grinten HL, Davies E, Deinum J, Flück CE, Kastelan D, Kroiss M, Mulatero P, Laakso S, Pearce SH, Reincke M, Reisch N, Robledo M, Ronchi CL, Vassiliadi DA, Wiegering V, Zennaro MC.   +24 more
europepmc   +1 more source

Dissociation of stimulatory effects of cortocotrophin on adrenal corticosterone and protein synthesis following hypophysectomy [PDF]

, 1968
Kluge, F., Scriba, Peter Christian
core  

Prolactin secretion in patients with pituitary tumors [PDF]

, 1974
Glöckner, B., Gottsmann, M., Pickardt, C. R., Rjosk, H. K., Scriba, Peter Christian, Werder, Klaus von   +5 more
core   +1 more source

The transcription factor HHEX maintains glucocorticoid levels and protects adrenals from androgen-induced lipid depletion. [PDF]

Nat Commun
Dumontet T, Basham KJ, Foster MC, Silverman E, Heard KA, Johnson D, Lee C, Plaska SW, Breault DT, Penton D, Beuschlein F, Turcu AF, LaPensee CR, Marcondes Lerario A, Hammer GD.   +14 more
europepmc   +1 more source

C‐X‐C chemokine receptor CXCR4 mediates diurnal changes in the aggregation and dispersion of CD8+ T cells within the tumor microenvironment

International Journal of Cancer, Volume 158, Issue 6, Page 1740-1754, 15 March 2026.
What's new? In addition to governing daily variations in biological activity, the circadian clock regulates immune cell migration into tumors. Whether this influence extends to immune cell localization within the tumor microenvironment (TME) is unknown. Here, using cell and animal models, the authors investigated immune cell distribution within the TME
Akito Tsuruta, Marina Fujimoto, Yasuha Hiraoka, Aoi Taniguchi, Yuki Shiiba, Takuto Inoki, Tomoaki Yamauchi, Yuya Yoshida, Naoya Matsunaga, Shigehiro Ohdo, Satoru Koyanagi   +10 more
wiley   +1 more source